Why I Just Invested in This Dividend King -- Even Though a Smaller Rival Has Grown Faster.

The author favors Procter & Gamble over faster-growing Church & Dwight for long-term total returns, citing P&G’s forward valuation below 22x earnings and roughly 3% dividend yield versus Church & Dwight at 26x and about 1.2%. P&G targets mid- to high-single-digit core EPS growth; the author estimates 5% annual earnings growth plus the dividend could yield about 8% annualized returns, with potential for 9%–10% if growth or valuation improves. Church & Dwight targets 4% long-term organic sales growth and 8%+ EPS growth, but the article notes its returns could fall to about 6.5% under slower growth and multiple contraction.

Analysis

The investable question is not which brand portfolio is “better,” but how much growth investors are paying for and how resilient that growth is. CHD’s higher multiple leaves less room for execution slippage: if organic growth or margin gains disappoint, earnings deceleration and multiple compression can compound. Its reliance on a concentrated set of power brands, acquisitions and efficiency gains also makes the durability of the growth target worth testing against volume, pricing and acquisition contribution—not just adjusted EPS. PG’s higher yield offers more carry, but is not a catalyst by itself; a rerating requires evidence that volume and margins are recovering without sacrificing share through pricing or mix.

Near term, the relative thesis is vulnerable to inflation-driven consumer trade-down and weak category volumes at both companies. Over 1–3 months, earnings commentary on unit volumes, price/mix, gross margins and guidance should matter more than the article’s decade-long return scenarios. Over 6–18 months, sustained margin recovery would strengthen PG’s case; persistent volume weakness or renewed input-cost pressure would undermine it. The contrarian point: the valuation gap may be justified if CHD’s faster growth proves more durable, while PG’s apparent value could be a value trap if its growth and margins remain impaired. Verify current forward multiples and comparable organic-growth definitions before sizing a relative trade.

Key Decisions for Investors

• Consider a modest, beta-aware long PG / short CHD relative-value position only if updated valuation data still show a meaningful premium for CHD; size for company-specific exposure and account for PG’s dividend carry versus the short’s dividend obligation.
• Use upcoming results as the near-term catalyst check: favor PG if volume trends and margins improve while guidance holds; reduce or exit the pair if PG loses share or cuts guidance, or if CHD sustains stronger organic growth and earnings conversion than expected.
• Do not underwrite the article’s decade-return estimates as forecasts. Track organic volume, price/mix, gross-margin direction, acquisition contribution and buyback effects to distinguish durable operating growth from EPS support by capital allocation.
• Avoid adding to PG solely on an assumed multiple rebound. A persistent margin/volume deterioration would falsify the recovery thesis; sustained CHD growth with stable margins would falsify the short-CHD leg.